Clinical

This channel newsfeed includes clinical content on treating patients or the clinical implications in a variety of cardiac subspecialties and disease states. The channel includes news on cardiac surgery, interventional cardiology, heart failure, electrophysiology, hypertension, structural heart disease, use of pharmaceuticals, and COVID-19.

Ultrasound RDN system launches in Japan—cardiologist calls it a ‘significant step forward’
Recor Medical's Paradise Ultrasound RDN technology is now available in Japan, home to an estimated 43 million adults with hypertension.
How recreational Adderall use affects the heart: a cardiologist’s warning
Students sometimes take unprescribed Adderall to stay up late and study. According to new research out of Mayo Clinic, however, that may do more to the heart than those students realize.
SCAI celebrates new federal funding for PAD prevention
The group's hope is that these new funds will help address the rising rates of PAD and CLTI throughout the United States.
FDA confirms more recalls for Johnson & Johnson heart pumps due to malfunction risk
The issue, first announced to the public in February, has been linked to 22 serious injuries. Customers are urged to review the updated instructions for use to avoid any potential complications.
Johnson & Johnson launches 3 new stroke devices
These devices were developed to help clinicians reach and remove distal clots associated with significant pain and swelling. If left untreated, such clots can lead to medical emergencies and even death.

iron bioresorbable scaffold Biotyx Medical

Ultrathin iron bioresorbable scaffold shows promise in first randomized trial

An investigational device could help interventional cardiologists avoid the limitations of drug-eluting stents, according to a new analysis published in JACC.

Nathaniel Lebowitz, MD, in charge of preventive cardiology at Hackensack University Medical Center, and assistant professor of internal medicine at Hackensack Meridian School of Medicine, gives an overview of where things are at with lipoprotein (a) awareness, testing and drug development. He and is working on the American Heart Associations (AHA) Lp(a) Discovery Project to expand awareness to both physicians and patients. #AHA #LPA

Cardiologist discusses Lp(a), the CVD risk factor responsible for many surprise heart attacks

Cardiologist Nathaniel Lebowitz, MD, reviews the latest updates in lipoprotein(a) awareness, testing and drug development.

REVENUE MONEY INCREASE DOLLAR GRAPH FINANCE

Edwards celebrates double-digit TAVR sales growth in Q4

It was another strong quarter for Edwards Lifesciences as the company's TAVR platform continues to gain momentum. The FDA's approval of multiple Edwards valves for the treatment of asymptomatic severe AS represents a potential game-changer for the entire industry.

New heart catheter for cell therapy delivery 1 step closer to FDA approval

The BioCardia delivery catheter was designed to be used by interventional cardiologists, electrophysiologists or cardiac surgeons. It includes a tiny needle that directly engages with the patient’s cardiac tissue.

University launches clinical trial for groundbreaking nuclear medicine cancer treatment

The University of Missouri Research Reactor will play a key role in the trial, as it is the only domestic producer of Y-90.

Blood glucose monitor instructions updated due to error code linked to 114 injuries

No devices need to be returned or replaced, but the company did want to update their instructions for use.

Scientists discover link between Alzheimer's and long COVID on MRI scans

Imaging findings pertaining to the size of and blood flowing to the choroid plexus may be a common denominator between the two conditions.

Stroke risk after TAVR still higher for woman as ‘sex paradox’ lives on

By tracking sex-related differences after TAVR, researchers hope to refine patient selection strategies and optimize care for both men and women.

Clinical

Ultrasound RDN system launches in Japan—cardiologist calls it a ‘significant step forward’

How recreational Adderall use affects the heart: a cardiologist’s warning

SCAI celebrates new federal funding for PAD prevention

FDA confirms more recalls for Johnson & Johnson heart pumps due to malfunction risk

Johnson & Johnson launches 3 new stroke devices